142 related articles for article (PubMed ID: 12450688)
1. Longevity of neutralizing antibody levels in macaques vaccinated with Quil A-adjuvanted measles vaccine candidates.
Stittelaar KJ; Vos HW; van Amerongen G; Kersten GF; Osterhaus AD; de Swart RL
Vaccine; 2002 Dec; 21(3-4):155-7. PubMed ID: 12450688
[TBL] [Abstract][Full Text] [Related]
2. In vivo antibody response and in vitro CTL activation induced by selected measles vaccine candidates, prepared with purified Quil A components.
Stittelaar KJ; Boes J; Kersten GF; Spiekstra A; Mulder PG; de Vries P; Roholl PJ; Dalsgaard K; van den Dobbelsteen G; van Alphen L; Osterhaus AD
Vaccine; 2000 May; 18(23):2482-93. PubMed ID: 10775782
[TBL] [Abstract][Full Text] [Related]
3. Protective immunity in macaques vaccinated with a modified vaccinia virus Ankara-based measles virus vaccine in the presence of passively acquired antibodies.
Stittelaar KJ; Wyatt LS; de Swart RL; Vos HW; Groen J; van Amerongen G; van Binnendijk RS; Rozenblatt S; Moss B; Osterhaus AD
J Virol; 2000 May; 74(9):4236-43. PubMed ID: 10756037
[TBL] [Abstract][Full Text] [Related]
4. A chimeric alphavirus replicon particle vaccine expressing the hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques from measles.
Pan CH; Greer CE; Hauer D; Legg HS; Lee EY; Bergen MJ; Lau B; Adams RJ; Polo JM; Griffin DE
J Virol; 2010 Apr; 84(8):3798-807. PubMed ID: 20130066
[TBL] [Abstract][Full Text] [Related]
5. Protection against challenge with measles virus (MV) in infant macaques by an MV DNA vaccine administered in the presence of neutralizing antibody.
Premenko-Lanier M; Rota PA; Rhodes GH; Bellini WJ; McChesney MB
J Infect Dis; 2004 Jun; 189(11):2064-71. PubMed ID: 15143474
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of recombinant vaccinia virus--measles vaccines in infant rhesus macaques with preexisting measles antibody.
Zhu Yd; Rota P; Wyatt L; Tamin A; Rozenblatt S; Lerche N; Moss B; Bellini W; McChesney M
Virology; 2000 Oct; 276(1):202-13. PubMed ID: 11022008
[TBL] [Abstract][Full Text] [Related]
7. Successful vaccine-induced seroconversion by single-dose immunization in the presence of measles virus-specific maternal antibodies.
Schlereth B; Rose JK; Buonocore L; ter Meulen V; Niewiesk S
J Virol; 2000 May; 74(10):4652-7. PubMed ID: 10775601
[TBL] [Abstract][Full Text] [Related]
8. Protective immunity in macaques vaccinated with live attenuated, recombinant, and subunit measles vaccines in the presence of passively acquired antibodies.
van Binnendijk RS; Poelen MC; van Amerongen G; de Vries P; Osterhaus AD
J Infect Dis; 1997 Mar; 175(3):524-32. PubMed ID: 9041322
[TBL] [Abstract][Full Text] [Related]
9. Use of Vaxfectin adjuvant with DNA vaccine encoding the measles virus hemagglutinin and fusion proteins protects juvenile and infant rhesus macaques against measles virus.
Pan CH; Jimenez GS; Nair N; Wei Q; Adams RJ; Polack FP; Rolland A; Vilalta A; Griffin DE
Clin Vaccine Immunol; 2008 Aug; 15(8):1214-21. PubMed ID: 18524884
[TBL] [Abstract][Full Text] [Related]
10. Leaf saponins of Quillaja brasiliensis enhance long-term specific immune responses and promote dose-sparing effect in BVDV experimental vaccines.
Cibulski S; Rivera-Patron M; Suárez N; Pirez M; Rossi S; Yendo AC; de Costa F; Gosmann G; Fett-Neto A; Roehe PM; Silveira F
Vaccine; 2018 Jan; 36(1):55-65. PubMed ID: 29174676
[TBL] [Abstract][Full Text] [Related]
11. Vaxfectin adjuvant improves antibody responses of juvenile rhesus macaques to a DNA vaccine encoding the measles virus hemagglutinin and fusion proteins.
Lin WH; Vilalta A; Adams RJ; Rolland A; Sullivan SM; Griffin DE
J Virol; 2013 Jun; 87(12):6560-8. PubMed ID: 23552419
[TBL] [Abstract][Full Text] [Related]
12. Poor immune responses of newborn rhesus macaques to measles virus DNA vaccines expressing the hemagglutinin and fusion glycoproteins.
Polack FP; Lydy SL; Lee SH; Rota PA; Bellini WJ; Adams RJ; Robinson HL; Griffin DE
Clin Vaccine Immunol; 2013 Feb; 20(2):205-10. PubMed ID: 23239799
[TBL] [Abstract][Full Text] [Related]
13. Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies.
de Swart RL; Yüksel S; Langerijs CN; Muller CP; Osterhaus ADME
J Gen Virol; 2009 Dec; 90(Pt 12):2982-2989. PubMed ID: 19710253
[TBL] [Abstract][Full Text] [Related]
14. Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and/or fusion proteins.
Song MK; Vindurampulle CJ; Capozzo AV; Ulmer J; Polo JM; Pasetti MF; Barry EM; Levine MM
J Virol; 2005 Aug; 79(15):9854-61. PubMed ID: 16014946
[TBL] [Abstract][Full Text] [Related]
15. Successful mucosal immunization of cotton rats in the presence of measles virus-specific antibodies depends on degree of attenuation of vaccine vector and virus dose.
Schlereth B; Buonocore L; Tietz A; Meulen VT; Rose JK; Niewiesk S
J Gen Virol; 2003 Aug; 84(Pt 8):2145-2151. PubMed ID: 12867646
[TBL] [Abstract][Full Text] [Related]
16. Vaccine strategies to overcome maternal antibody mediated inhibition of measles vaccine.
Osterhaus A; van Amerongen G; van Binnendijk R
Vaccine; 1998; 16(14-15):1479-81. PubMed ID: 9711792
[TBL] [Abstract][Full Text] [Related]
17. Passively administered antibody suppresses the induction of measles virus antibodies by vaccinia-measles recombinant viruses.
Galletti R; Beauverger P; Wild TF
Vaccine; 1995 Feb; 13(2):197-201. PubMed ID: 7625116
[TBL] [Abstract][Full Text] [Related]
18. Probing neutralizing-antibody responses against emerging measles viruses (MVs): immune selection of MV by H protein-specific antibodies?
Santibanez S; Niewiesk S; Heider A; Schneider-Schaulies J; Berbers GAM; Zimmermann A; Halenius A; Wolbert A; Deitemeier I; Tischer A; Hengel H
J Gen Virol; 2005 Feb; 86(Pt 2):365-374. PubMed ID: 15659756
[TBL] [Abstract][Full Text] [Related]
19. Recombinant bacille Calmette-Guérin expressing the measles virus nucleoprotein protects infant rhesus macaques from measles virus pneumonia.
Zhu YD; Fennelly G; Miller C; Tarara R; Saxe I; Bloom B; McChesney M
J Infect Dis; 1997 Dec; 176(6):1445-53. PubMed ID: 9395353
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of rhesus macaques with a recombinant measles virus expressing interleukin-12 alters humoral and cellular immune responses.
Hoffman SJ; Polack FP; Hauer DA; Singh M; Billeter MA; Adams RJ; Griffin DE
J Infect Dis; 2003 Nov; 188(10):1553-61. PubMed ID: 14624382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
